acute myocardial infarction

synergy vs XIENCE

SYNERGY vs. XIENCE in Complex Real-World Patients

Courtesy of Dr. Guillermo Migliaro. Technological advancements in drug-eluting stents (DES) have shown significant improvement as regards the safety and efficacy of these devices. DES are considered to be the golden standard for the treatment of percutaneous coronary interventions. &nbsp; DES with permanent or durable polymers (DP) have been associated with local inflammatory reactions and<a href="https://solaci.org/en/2017/04/01/synergy-vs-xience-in-complex-real-world-patients/" title="Read more" >...</a>

anuloplastia mitral percutánea

Percutaneous Mitral Annuloplasty: First Results in Humans

&nbsp;Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia.&nbsp; In the last few years, new percutaneous treatment options for mitral regurgitation have emerged. Transcatheter mitral annuloplasty with various devices is a relatively simple procedure that could compress the origin of circumflex artery branches due to the different orientation of mitral corners and the coronary sinus. &nbsp; The following work by Park<a href="https://solaci.org/en/2017/03/27/percutaneous-mitral-annuloplasty-first-results-in-humans/" title="Read more" >...</a>

desensibilizacion a la aspirina

Aspirin Desensitization in Patients with Coronary Artery Disease

There are limited data on aspirin desensitization in patients with coronary artery disease (CAD). The aim of this study was to test the safety and efficacy of a rapid desensitization protocol inpatients with a history of aspirin sensitivity about to receive PCI. &nbsp; This was a prospective multicenter observational study, carried out in seven Italian<a href="https://solaci.org/en/2017/03/06/aspirin-desensitization-in-patients-with-coronary-artery-disease/" title="Read more" >...</a>

tromboaspiracion angioplastia primaria

Thrombus Aspiration during Primary PCI Does Not Improve Clinical Outcomes

Thrombus aspiration during primary PCI in ST elevation MI has been extensively used; however, recent studies have questioned its efficacy and safety. &nbsp; This meta-analysis looked into individual patient data to determine the benefit and safety of thrombus aspiration during primary PCI. &nbsp; It included all randomized and controlled studies assessing manual thrombectomy vs. conventional<a href="https://solaci.org/en/2017/01/09/thrombus-aspiration-during-primary-pci-does-not-improve-clinical-outcomes/" title="Read more" >...</a>

ticagrelor vs clopidogrel en enfermedad vascular periferica

Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Vascular Disease

Peripheral vascular disease is considered as a manifestation of systemic atherosclerosis associated with adverse events, both cardiovascular and related to the lower limbs. &nbsp; Previous studies showed that clopidogrel monotherapy is associated with lower risk of events when compared to low doses of aspirin. Such is the rationale behind this article comparing clopidogrel and ticagrelor<a href="https://solaci.org/en/2017/01/04/ticagrelor-versus-clopidogrel-in-symptomatic-peripheral-vascular-disease/" title="Read more" >...</a>

pacientes anticoagulados por fibrilación auricular que reciben angioplastia tratamiento

Anticoagulated Patients with Atrial Fibrillation Undergoing Angioplasty: How to Treat Them

In patients with atrial fibrillation undergoing coronary angioplasty with stents, standard anticoagulation with vitamin K antagonists plus dual antiplatelet therapy with a P2Y12 inhibitor and aspirin reduces the risk of stent thrombosis and stroke, but increases the risk of bleeding. &nbsp; The effectiveness and safety of anticoagulation with rivaroxaban plus one or two antiplatelet agents<a href="https://solaci.org/en/2016/12/26/anticoagulated-patients-with-atrial-fibrillation-undergoing-angioplasty-how-to-treat-them/" title="Read more" >...</a>

FUTURE: aumento de la mortalidad en la rama FFR

FUTURE: Mortality Increase in the FFR Arm, Real or Casual?

The FUTURE study, testing the&nbsp;utility of functional revascularization by measuring the fractional flow reserve (FFR), was halted early by its safety committee due to an increased mortality rate at 1&nbsp;year among patients guided by FFR. &nbsp; In this unexpected unprecedented outcome, 17&nbsp;patients in the FFR-guided group died at a year of follow-up, compared with 7&nbsp;patients<a href="https://solaci.org/en/2016/12/01/future-mortality-increase-in-the-ffr-arm-real-or-casual/" title="Read more" >...</a>

angioplastia en centros sin apoyo quirúrgico

Is Angioplasty at Centers Without Surgical Backup Safe?

Performing coronary angioplasties at hospitals without surgical backup seems to be safe for a wide variety of patients, from those presenting ST-segment elevation myocardial infarction to those undergoing elective procedures. &nbsp; This work responds to a long-running debate over whether centers without on-site surgery capabilities in case of complications can be considered as referral centers<a href="https://solaci.org/en/2016/12/01/is-angioplasty-at-centers-without-surgical-backup-safe/" title="Read more" >...</a>

tavi anestesia local

Local Anesthesia for TAVR Was Safe and Reduced Hospital Stays

A minimalist approach to transcatheter aortic valve replacement (TAVR) involving local anesthesia appears to have several advantages, according to this new meta-analysis. &nbsp; In addition to shortening times for procedures and lengths of stay in the critical care unit and hospital, lighter sedation may lower the need for transfusions or treatment with inotropes or vasopressors.<a href="https://solaci.org/en/2016/12/01/local-anesthesia-for-tavr-was-safe-and-reduced-hospital-stays/" title="Read more" >...</a>

Contemporary Ventricular Assist Devices: Hemodynamic Consequences

Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia. Despite current technological advancements and improvement in reperfusion rates in a setting of infarction, cardiogenic shock still is a relatively frequent complication with a mortality rate close to 50%. The need to augment cardiac output in these patients and the fact that the popular intraaortic balloon counterpulsation has not been able to<a href="https://solaci.org/en/2016/11/25/contemporary-ventricular-assist-devices-hemodynamic-consequences/" title="Read more" >...</a>

Top